Skip to main content

Table 4 Changes in adipokines during the weight loss period 1

From: Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations

  

IFCR-L

  

IFCR-F

 
 

Week 3

Week 10

Change2

Week 3

Week 10

Change2

Leptin (ng/ml)

36.5 ± 2.5

27.1 ± 3.1 3

−9.4 ± 1.6

37.6 ± 2.5

29.4 ± 2.4 3

−8.2 ± 1.7

IL-6 (pg/ml)

3.1 ± 0.3

2.5 ± 0.3 3

−0.6 ± 0.3

3.1 ± 0.4

3.3 ± 0.4

0.2 ± 0.4

TNF-alpha (pg/ml)

1.6 ± 0.3

1.2 ± 0.3 3

−0.4 ± 0.1

1.2 ± 0.3

1.1 ± 0.2

−0.1 ± 0.1

C-Reactive protein (mg/dl)

0.4 ± 0.1

0.4 ± 0.1

0 ± 0.1

0.6 ± 0.2

0.4 ± 0.1

−0.2 ± 0.2

8-isoprostane (pmol/mg)

1.8 ± 0.1

1.9 ± 0.1

0.1 ± 0.1

1.8 ± 0.1

1.9 ± 0.1

0.1 ± 0.1

IGF-1 (ng/ml)

67.7 ± 3.8

60.8 ± 4.2 3

−6.9 ± 2.3

69.6 ± 3.8

67.6 ± 5.4

−2.0 ± 4.9

  1. 1 Values reported as mean ± SEM. IFCR-L: Intermittent fasting calorie restriction-liquid diet (n = 28); IFCR-F: Intermittent fasting calorie restriction-food based diet (n = 26). IL-6: Interleukin-6, TNF-alpha: Tumor necrosis factor-alpha, IGF-1: Insulin-like growth factor-1.
  2. 2 Change expressed as the difference between week 3 and week 10 absolute values.
  3. 3 Week 3 values significantly (P < 0.05) different from week 10 values within group (Repeated-measures ANOVA).